The National Cancer Institute (NCI) is offering this Mentored Research Scientist Development Award (K01) to enhance diversity within its funded cancer research workforce. This grant is for eligible individuals from diverse backgrounds, including groups nationally underrepresented in biomedical, behavioral, social, and clinical sciences. It provides salary and research support, enabling sustained ‘protected time’ for intensive career development under an experienced mentor. This opportunity specifically supports those proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. The NCI aims to foster a more diverse scientific community dedicated to cancer research advancements.
Opportunity ID: 335509
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-296 |
| Funding Opportunity Title: | NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.398 — Cancer Research Manpower |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 31, 2021 |
| Last Updated Date: | Aug 31, 2021 |
| Original Closing Date for Applications: | Nov 12, 2024 |
| Current Closing Date for Applications: | Nov 12, 2024 |
| Archive Date: | Dec 18, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education State governments Special district governments Independent school districts Native American tribal governments (Federally recognized) County governments For profit organizations other than small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded cancer research workforce by supporting eligible individuals from diverse backgrounds, including groups that have been shown to be nationally underrepresented in the biomedical, behavioral, social and clinical sciences. This FOA provides salary and research support for a sustained period of “protected time” for intensive research career development under the guidance of an experienced mentor. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-296.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 335509 Full Announcement-PAR-21-296 -> PAR-21-296-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270143 | Nov 15, 2021 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268775 | Sep 12, 2021 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278042 | Nov 07, 2022 | Nov 12, 2024 | View |
Package 1
Mandatory forms
335509 RR_SF424_5_0-5.0.pdf
335509 PHS398_CoverPageSupplement_5_0-5.0.pdf
335509 RR_OtherProjectInfo_1_4-1.4.pdf
335509 PerformanceSite_4_0-4.0.pdf
335509 RR_KeyPersonExpanded_4_0-4.0.pdf
335509 RR_Budget_3_0-3.0.pdf
335509 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf
335509 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335509 RR_SubawardBudget30_3_0-3.0.pdf
335509 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335509 RR_SF424_2_0-2.0.pdf
335509 PHS398_CoverPageSupplement_5_0-5.0.pdf
335509 RR_OtherProjectInfo_1_4-1.4.pdf
335509 PerformanceSite_2_0-2.0.pdf
335509 RR_KeyPersonExpanded_2_0-2.0.pdf
335509 RR_Budget_1_4-1.4.pdf
335509 PHS398_CareerDevelopmentAwardSup_5_0-5.0.pdf
335509 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335509 RR_SubawardBudget30_1_4-1.4.pdf
335509 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
335509 RR_SF424_5_0-5.0.pdf
335509 PHS398_CoverPageSupplement_5_0-5.0.pdf
335509 RR_OtherProjectInfo_1_4-1.4.pdf
335509 PerformanceSite_4_0-4.0.pdf
335509 RR_KeyPersonExpanded_4_0-4.0.pdf
335509 RR_Budget_3_0-3.0.pdf
335509 PHS398_CareerDevelopmentAwardSup_6_0-6.0.pdf
335509 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335509 RR_SubawardBudget30_3_0-3.0.pdf
335509 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
